Tsoupras Alexandros, Gkika Despina A, Siadimas Ilias, Christodoulopoulos Ioannis, Efthymiopoulos Pavlos, Kyzas George Z
Hephaestus Laboratory, Department of Chemistry, School of Science, Democritus University of Thrace, GR 65404 Kavala, Greece.
Pharmaceuticals (Basel). 2024 May 14;17(5):627. doi: 10.3390/ph17050627.
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely utilized pharmaceuticals worldwide. Besides their recognized anti-inflammatory effects, these drugs exhibit various other pleiotropic effects in several cells, including platelets. Within this article, the multifaceted properties of NSAIDs on platelet functions, activation and viability, as well as their interaction(s) with established antiplatelet medications, by hindering several platelet agonists' pathways and receptors, are thoroughly reviewed. The efficacy and safety of NSAIDs as adjunctive therapies for conditions involving inflammation and platelet activation are also discussed. Emphasis is given to the antiplatelet potential of commonly administered NSAIDs medications, such as ibuprofen, diclofenac, naproxen and ketoprofen, alongside non-opioid analgesic and antipyretic medications like paracetamol. This article delves into their mechanisms of action against different pathways of platelet activation, aggregation and overall platelet functions, highlighting additional health-promoting properties of these anti-inflammatory and analgesic agents, without neglecting the induced by these drugs' side-effects on platelets' functionality and thrombocytopenia. Environmental issues emerging from the ever-increased subscription of these drugs are also discussed, along with the need for novel water treatment methodologies for their appropriate elimination from water and wastewater samples. Despite being efficiently eliminated during wastewater treatment processes on occasion, NSAIDs remain prevalent and are found at significant concentrations in water bodies that receive effluents from wastewater treatment plants (WWTPs), since there is no one-size-fits-all solution for removing all contaminants from wastewater, depending on the specific characteristics of the wastewater. Several novel methods have been studied, with adsorption being proposed as a cost-effective and environmentally friendly method for wastewater purification from such drugs. This article also presents limitations and future prospects regarding the observed antiplatelet effects of NSAIDs, as well as the potential of novel derivatives of these compounds, with benefits in other important platelet functions.
非甾体抗炎药(NSAIDs)是全球使用最广泛的药物之一。除了其公认的抗炎作用外,这些药物在包括血小板在内的多种细胞中还表现出各种其他多效性作用。在本文中,我们全面回顾了NSAIDs对血小板功能、活化和活力的多方面特性,以及它们通过阻碍几种血小板激动剂的途径和受体与既定抗血小板药物的相互作用。还讨论了NSAIDs作为涉及炎症和血小板活化病症辅助治疗的疗效和安全性。重点介绍了常用NSAIDs药物(如布洛芬、双氯芬酸、萘普生和酮洛芬)以及对乙酰氨基酚等非阿片类镇痛和解热药物的抗血小板潜力。本文深入探讨了它们针对血小板活化、聚集和整体血小板功能不同途径的作用机制,强调了这些抗炎和镇痛药物的其他促进健康特性,同时也没有忽视这些药物对血小板功能和血小板减少症的副作用。还讨论了这些药物不断增加的使用所引发的环境问题,以及采用新型水处理方法从水和废水样本中适当去除这些药物的必要性。尽管NSAIDs有时在废水处理过程中能有效去除,但它们仍然普遍存在,并且在接收污水处理厂(WWTPs)废水的水体中以显著浓度被发现,因为根据废水的特定特征,没有一种万能的解决方案可以去除废水中的所有污染物。已经研究了几种新方法,吸附被提议作为一种从这类药物中净化废水的经济高效且环保的方法。本文还介绍了关于NSAIDs观察到的抗血小板作用的局限性和未来前景,以及这些化合物新型衍生物在其他重要血小板功能方面的潜力。